Diabetes Mellitus, Type 2 study: Focused App Prompt vs No App Prompt
Official title Real-time Engagement for Learning to Effectively Control Type 2 Diabetes
ClinicalTrials.gov ID: NCT06375460
What this study is testing
- What it's testing
- The study wants to find out if the app improves short‑term and long‑term blood sugar control and if it encourages more physical activity.
- Who it's for
- It is looking for adolescents and young adults who have type 2 diabetes.
- What's involved
- Participants will wear a continuous glucose monitor and an activity tracker for six months, use the study app, have three in‑person visits with blood tests, and record their food intake occasionally.
- Time commitment
- The study lasts six months and includes three clinic visits during that time.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 14 to 26
You may be able to join if
- type 2 diabetes: negative diabetes autoantibodies, no suspicion for monogenic diabetes
- English-speaking (app in English)
You likely can't join if
- Current pregnancy
- Hydroxyurea use (CGM sensor inaccuracies)
- Cognitive impairment or severe psychiatric condition that could interfere with participation in behavioral intervention for diabetes self-management
- Current or previously diagnosed eating disorder
The study team makes the final eligibility decision.
Where it is enrolling
- Pittsburgh, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 14 years to 26 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Pittsburgh, Pennsylvania, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.